Low inflammatory activity evidenced by hsCRP predicts a benefit from clopidogrel treatment in patients with high risk for cardiovascular events. A substudy from the CHARISMA trial

Weber, Michael W., Hamm, Christian W., Bhatt, Deepak L. and Topol, Eric J. (2007). Low inflammatory activity evidenced by hsCRP predicts a benefit from clopidogrel treatment in patients with high risk for cardiovascular events. A substudy from the CHARISMA trial. In: Abstracts from Scientific Sessions 2007. 80th Annual Scientific Session of the American Heart Association, Orlando, Florida USA, (801-801). 4-7 November 2007.


Author Weber, Michael W.
Hamm, Christian W.
Bhatt, Deepak L.
Topol, Eric J.
Title of paper Low inflammatory activity evidenced by hsCRP predicts a benefit from clopidogrel treatment in patients with high risk for cardiovascular events. A substudy from the CHARISMA trial
Conference name 80th Annual Scientific Session of the American Heart Association
Conference location Orlando, Florida USA
Conference dates 4-7 November 2007
Proceedings title Abstracts from Scientific Sessions 2007   Check publisher's open access policy
Journal name Circulation   Check publisher's open access policy
Place of Publication United States
Publisher Lippincott Williams & Wilkins
Publication Year 2007
Sub-type Published abstract
ISSN 0009-7322
1524-4539
Volume 116
Issue 16 Supp.
Start page 801
End page 801
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Non-UQ
Additional Notes Meeting Abstract: 3539

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Tue, 07 Dec 2010, 10:03:48 EST